Annual Shareholders Equity
$35.31 M
-$3.50 M-9.03%
31 December 2023
Summary:
Forte Biosciences annual stockholders equity is currently $35.31 million, with the most recent change of -$3.50 million (-9.03%) on 31 December 2023. During the last 3 years, it has fallen by -$23.67 million (-40.13%). FBRX annual shareholders equity is now -40.13% below its all-time high of $58.98 million, reached on 31 December 2020.FBRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$9.37 M
-$7.59 M-44.78%
30 September 2024
Summary:
Forte Biosciences quarterly stockholders equity is currently $9.37 million, with the most recent change of -$7.59 million (-44.78%) on 30 September 2024. Over the past year, it has dropped by -$31.04 million (-76.82%). FBRX quarterly shareholders equity is now -84.12% below its all-time high of $58.98 million, reached on 31 December 2020.FBRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBRX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.0% | -76.8% |
| 3 y3 years | -40.1% | -78.5% |
| 5 y5 years | - | - |
FBRX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -40.1% | at low | -78.5% | at low |
| 5 y | 5 years | -40.1% | at low | -84.1% | at low |
| alltime | all time | -40.1% | at low | -84.1% | at low |
Forte Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.37 M(-44.8%) |
| June 2024 | - | $16.96 M(-40.9%) |
| Mar 2024 | - | $28.68 M(-18.8%) |
| Dec 2023 | $35.31 M(-9.0%) | $35.31 M(-12.6%) |
| Sept 2023 | - | $40.41 M(+62.4%) |
| June 2023 | - | $24.88 M(-24.5%) |
| Mar 2023 | - | $32.95 M(-15.1%) |
| Dec 2022 | $38.82 M | $38.82 M(-9.4%) |
| Sept 2022 | - | $42.84 M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $38.21 M(-4.6%) |
| Mar 2022 | - | $40.05 M(-3.6%) |
| Dec 2021 | $41.55 M(-29.6%) | $41.55 M(-4.8%) |
| Sept 2021 | - | $43.65 M(-12.5%) |
| June 2021 | - | $49.91 M(-8.8%) |
| Mar 2021 | - | $54.70 M(-7.3%) |
| Dec 2020 | $58.98 M | $58.98 M(+190.3%) |
| Sept 2020 | - | $20.32 M(-18.3%) |
| June 2020 | - | $24.88 M |
FAQ
- What is Forte Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Forte Biosciences?
- What is Forte Biosciences annual shareholders equity year-on-year change?
- What is Forte Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Forte Biosciences?
- What is Forte Biosciences quarterly shareholders equity year-on-year change?
What is Forte Biosciences annual stockholders equity?
The current annual shareholders equity of FBRX is $35.31 M
What is the all time high annual shareholders equity for Forte Biosciences?
Forte Biosciences all-time high annual stockholders equity is $58.98 M
What is Forte Biosciences annual shareholders equity year-on-year change?
Over the past year, FBRX annual stockholders equity has changed by -$3.50 M (-9.03%)
What is Forte Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of FBRX is $9.37 M
What is the all time high quarterly shareholders equity for Forte Biosciences?
Forte Biosciences all-time high quarterly stockholders equity is $58.98 M
What is Forte Biosciences quarterly shareholders equity year-on-year change?
Over the past year, FBRX quarterly stockholders equity has changed by -$31.04 M (-76.82%)